Literature DB >> 30710244

The impact of experience on short- and long-term outcomes on gastric ESD: a western series.

F Catalano1, V Mengardo2, A Trecca3, A Tomezzoli4, L Rodella1, A Cerofolini1, G Verlato5, G de Manzoni6.   

Abstract

Endoscopic submucosal dissection (ESD) represents the standard of care for early gastric cancer in Eastern countries. Nevertheless, in the West, this procedure is not widespread. Aim of the study was to confirm the feasibility and the efficacy of ESD in the West. A total of 60 ESD were performed between January 2005 and December 2014 by two expert endoscopists. The analysis, based on a retrospective collected database, was conducted by dividing the study period in three subgroups. Clinical and technical outcomes have been compared. Rates of complete, curative and en bloc resection did not significantly change among the study periods. Three cases of perforation occurred (5%), one in each period. The operation time significantly decreased from the second to the third period (p < 0.001). When adjusting for gender, tumor size and site in multivariable analysis, operation time decreased by nearly 90 min from the first to the second period, and by more than 3 h from the first to the last period. The median follow-up was 33 months. No cases of local or lymphnodal recurrence were detected during the study period. One patient presented a synchronous lesion, whilst four metachronous lesions have been discovered after a median follow-up of 11 months. Our experience supports the feasibility and safety of ESD in the West, if an adequate learning curve is accomplished. Long-term outcomes are comparable to the Eastern series.

Entities:  

Keywords:  ESD; Early gastric cancer; Gastric cancer; Western experience

Mesh:

Substances:

Year:  2019        PMID: 30710244     DOI: 10.1007/s13304-019-00628-1

Source DB:  PubMed          Journal:  Updates Surg        ISSN: 2038-131X


  27 in total

1.  Endoscopic submucosal dissection for gastric lesions: results of an European inquiry.

Authors:  F Ribeiro-Mourão; P Pimentel-Nunes; M Dinis-Ribeiro
Journal:  Endoscopy       Date:  2010-09-30       Impact factor: 10.093

Review 2.  Endoscopic mucosal resection in the stomach using the insulated-tip needle-knife.

Authors:  M Muto; S Miyamoto; A Hosokawa; T Doi; A Ohtsu; S Yoshida; Y Endo; K Hosokawa; D Saito; C-S Shim; L Gossner
Journal:  Endoscopy       Date:  2005-02       Impact factor: 10.093

3.  Endoscopic submucosal dissection of early cancers, flat adenomas, and submucosal tumors in the gastrointestinal tract.

Authors:  Andreas Probst; Daniela Golger; Hans Arnholdt; Helmut Messmann
Journal:  Clin Gastroenterol Hepatol       Date:  2008-09-20       Impact factor: 11.382

4.  The modern treatment of early gastric cancer: our experience in an Italian cohort.

Authors:  Filippo Catalano; Antonello Trecca; Luca Rodella; Francesco Lombardo; Anna Tomezzoli; Serena Battista; Marco Silano; Fabio Gaj; Giovanni de Manzoni
Journal:  Surg Endosc       Date:  2009-03-05       Impact factor: 4.584

5.  How to justify endoscopic submucosal dissection in the Western world.

Authors:  J J Bergman
Journal:  Endoscopy       Date:  2009-10-28       Impact factor: 10.093

Review 6.  Detection and treatment of early cancer in high-risk populations.

Authors:  Shigeaki Yoshida; Takahiro Kozu; Takuji Gotoda; Daizo Saito
Journal:  Best Pract Res Clin Gastroenterol       Date:  2006       Impact factor: 3.043

7.  Incidence of lymph node metastasis from early gastric cancer: estimation with a large number of cases at two large centers.

Authors:  Takuji Gotoda; Akio Yanagisawa; Mitsuru Sasako; Hiroyuki Ono; Yukihiro Nakanishi; Tadakazu Shimoda; Yo Kato
Journal:  Gastric Cancer       Date:  2000-12       Impact factor: 7.370

8.  Risk factors for lymph node metastases and their prognostic significance in early gastric cancer (EGC) for the Italian Research Group for Gastric Cancer (IRGGC).

Authors:  S Folli; P Morgagni; F Roviello; G De Manzoni; D Marrelli; L Saragoni; A Di Leo; M Gaudio; O Nanni; A Carli; C Cordiano; D Dell'Amore; A Vio
Journal:  Jpn J Clin Oncol       Date:  2001-10       Impact factor: 3.019

9.  Endoscopic resection of early gastric cancer treated by guideline and expanded National Cancer Centre criteria.

Authors:  T Gotoda; M Iwasaki; C Kusano; S Seewald; I Oda
Journal:  Br J Surg       Date:  2010-06       Impact factor: 6.939

10.  Endoscopic submucosal dissection allows curative resection of locally recurrent early gastric cancer after prior endoscopic mucosal resection.

Authors:  Chizu Yokoi; Takuji Gotoda; Hisanao Hamanaka; Ichiro Oda
Journal:  Gastrointest Endosc       Date:  2006-08       Impact factor: 9.427

View more
  4 in total

1.  Perioperative Glucocorticoids are Associated with Improved Recurrence-Free Survival After Pancreatic Cancer Surgery: A Retrospective Cohort Study with Propensity Score-Matching.

Authors:  Yun-Xiao Zhang; Dong-Liang Mu; Ke-Min Jin; Xue-Ying Li; Dong-Xin Wang
Journal:  Ther Clin Risk Manag       Date:  2021-01-22       Impact factor: 2.423

2.  Implementation of endoscopic submucosal dissection in a country with a low incidence of gastric cancer: Results from a prospective national registry.

Authors:  Gloria Fernández-Esparrach; José-Carlos Marín-Gabriel; Alberto H de Tejada; Eduardo Albéniz; Oscar Nogales; Andres J Del Pozo-García; Pedro J Rosón; Unai Goicotxea; Hugo Uchima; Alvaro Terán; Alvarez Alberto; Rodríguez-Sánchez Joaquín; Rivero-Sánchez Liseth; Santiago José
Journal:  United European Gastroenterol J       Date:  2021-06-02       Impact factor: 4.623

3.  A Single-Center Early Experience of Endoscopic Submucosal Dissection for Gastric Lesions in Thailand.

Authors:  Prasit Mahawongkajit
Journal:  Gastroenterol Res Pract       Date:  2020-01-30       Impact factor: 2.260

4.  Risk factor-based optimal endoscopic surveillance intervals after endoscopic submucosal dissection for gastric adenoma.

Authors:  Choong-Kyun Noh; Eunyoung Lee; Gil Ho Lee; Sun Gyo Lim; Kee Myung Lee; Jin Roh; Young Bae Kim; Bumhee Park; Sung Jae Shin
Journal:  Sci Rep       Date:  2021-11-01       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.